Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
$6.15
-0.8%
$6.24
$1.70
$40.00
$35.12M4.9848,665 shs83,556 shs
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
$9.84
+3.0%
$13.45
$3.25
$20.75
$133.78M2.14172,280 shs164,462 shs
Veritone, Inc. stock logo
VERI
Veritone
$1.29
+0.8%
$1.06
$0.76
$9.42
$128.59M2.262.77 million shs2.85 million shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.96
+6.1%
$3.85
$2.11
$21.41
$147.87M-0.25368,983 shs318,105 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
-0.81%+8.08%-14.70%-31.44%-24.43%
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
+3.04%+10.69%-20.06%-11.59%-8.84%
Veritone, Inc. stock logo
VERI
Veritone
+0.78%+18.35%+50.67%+0.78%-78.17%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+6.09%+29.26%-19.13%-75.74%-83.42%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
$6.15
-0.8%
$6.24
$1.70
$40.00
$35.12M4.9848,665 shs83,556 shs
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
$9.84
+3.0%
$13.45
$3.25
$20.75
$133.78M2.14172,280 shs164,462 shs
Veritone, Inc. stock logo
VERI
Veritone
$1.29
+0.8%
$1.06
$0.76
$9.42
$128.59M2.262.77 million shs2.85 million shs
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$2.96
+6.1%
$3.85
$2.11
$21.41
$147.87M-0.25368,983 shs318,105 shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
-0.81%+8.08%-14.70%-31.44%-24.43%
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
+3.04%+10.69%-20.06%-11.59%-8.84%
Veritone, Inc. stock logo
VERI
Veritone
+0.78%+18.35%+50.67%+0.78%-78.17%
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
+6.09%+29.26%-19.13%-75.74%-83.42%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
1.50
ReduceN/AN/A
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
1.50
ReduceN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
2.40
Hold$6.13374.81% Upside
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BGDE, ZSQR, RTB, and VERI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/16/2026
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
UpgradeSell (E)Sell (E+)
9/11/2026
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
Reiterated RatingSell (D-)
9/9/2026
Veritone, Inc. stock logo
VERI
Veritone
UpgradeSell (E+)Sell (D-)
8/25/2026
Veritone, Inc. stock logo
VERI
Veritone
DowngradeSell (D-)Sell (E+)
8/24/2026
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
DowngradeSell (E+)Sell (E)
8/14/2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
DowngradeSell (D-)Sell (E-)
8/14/2026
Veritone, Inc. stock logo
VERI
Veritone
Lower Price TargetBuy$5.00
8/11/2026
Veritone, Inc. stock logo
VERI
Veritone
UpgradeSell (E+)Sell (D-)
7/15/2026
Veritone, Inc. stock logo
VERI
Veritone
DowngradeSell (D-)Sell (E+)
6/23/2026
Veritone, Inc. stock logo
VERI
Veritone
UpgradeSell (E+)Sell (D-)
(Data available from 9/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
$39.75M0.88N/AN/A($0.86) per share-7.15
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
$11.13M12.39N/AN/A$0.65 per share15.14
Veritone, Inc. stock logo
VERI
Veritone
$92.19M1.41N/AN/A$0.74 per share1.74
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
$1.36M115.35N/AN/A$2.63 per share1.13
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
-$23.66M-$12.60N/AN/AN/A-80.68%-2,070.87%-40.61%N/A
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
-$17.53M-$6.36N/AN/AN/A-216.56%-342.57%-101.47%N/A
Veritone, Inc. stock logo
VERI
Veritone
-$111.73M-$0.38N/AN/AN/A-111.90%-159.15%-39.63%11/12/2026 (Estimated)
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
-$11.92M-$1.63N/AN/AN/A-773.72%-49.45%-46.88%N/A

Latest BGDE, ZSQR, RTB, and VERI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
N/A-$1.33N/A-$1.33N/A$6.15 million
8/14/2026Q2 2026
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
N/A-$1.24N/A-$1.24N/A$2.33 million
8/13/2026Q2 2026
Veritone, Inc. stock logo
VERI
Veritone
-$0.1106-$0.11+$0.0006-$0.24$28.29 million$24.26 million
8/13/2026Q2 2026
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A-$0.28N/A-$0.28N/A$1.58 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
N/AN/AN/AN/AN/A
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
N/AN/AN/AN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
N/AN/AN/AN/AN/A
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
N/A
0.71
0.71
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
0.05
1.37
1.37
Veritone, Inc. stock logo
VERI
Veritone
N/A
0.47
0.47
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
N/A
7.66
7.66
CompanyEmployeesShares OutstandingFree FloatOptionable
Big Digital Energy, Inc. Common Stock stock logo
BGDE
Big Digital Energy, Inc. Common Stock
405.66 million5.55 millionNot Optionable
RTB Digital, Inc. Common Stock stock logo
RTB
RTB Digital, Inc. Common Stock
5014.01 million12.27 millionNo Data
Veritone, Inc. stock logo
VERI
Veritone
446100.46 million93.05 millionOptionable
Coeptis Therapeutics Holdings, Inc. stock logo
ZSQR
Coeptis Therapeutics
653.00 million40.15 millionNot Optionable

Recent News About These Companies

Z Squared Inc. Provides Capital Structure Update

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Big Digital Energy, Inc. Common Stock stock logo

Big Digital Energy, Inc. Common Stock NASDAQ:BGDE

$6.15 -0.05 (-0.81%)
As of 09/23/2026 04:00 PM Eastern

Mawson Infrastructure Group Inc. develops and operates digital infrastructure for digital currency on the bitcoin blockchain network in the United States. It engages in digital currency or bitcoin self-mining, customer co-location and related services, and energy markets, as well as operates data center facilities. The company is based in Midland, Pennsylvania.

RTB Digital, Inc. Common Stock stock logo

RTB Digital, Inc. Common Stock NASDAQ:RTB

$9.84 +0.29 (+3.04%)
As of 09/23/2026 04:00 PM Eastern

Ryvyl Inc., a technology company, engages in the development, marketing, and sale of blockchain-based payment solutions in North America, Europe, and Asia. The company's blockchain-based systems facilitate, record, and store a volume of tokenized assets representing cash or data on a blockchain-based ledger. Its products include QuickCard Payment System, a physical and virtual payment card processing management system, including software that facilitates on and off ramp e-wallet management; Coyni, a digital token platform, which offers custodial assurance by utilizing its stable coin and blockchain technology in a closed-loop ecosystem; and ChargeSavvy, an end-to-end POS solution comprising software and hardware for the restaurant and hospitality industry. It serves customers in various industries, including foreign exchange, retail, and e-commerce sectors. The company was formerly known as GreenBox POS and changed its name to Ryvyl Inc. in October 2022. Ryvyl Inc. is based in San Diego, California.

Veritone stock logo

Veritone NASDAQ:VERI

$1.29 +0.01 (+0.78%)
Closing price 09/23/2026 04:00 PM Eastern
Extended Trading
$1.26 -0.03 (-2.02%)
As of 05:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Veritone, Inc., together with its subsidiaries, engages in the provision of artificial intelligence (AI) computing solutions and services in the United States, the United Kingdom, France, Australia, Israel, and India. It develops and operates aiWARE platform, an AI operating system, that uses machine learning algorithms or AI models designed to mimic human cognitive functions, such as perception, prediction, and problem solving and optimization, as well as enables users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, government, legal and compliance, energy, and other vertical markets. The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.

Coeptis Therapeutics stock logo

Coeptis Therapeutics NASDAQ:ZSQR

$2.96 +0.17 (+6.09%)
As of 09/23/2026 04:00 PM Eastern

Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company also offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.